Ȩ Ä«Å×°í¸® ¸ÂÃãÇü½ÃÀåÁ¶»ç ±¹Á¦ÄÁÆÛ·±½º ±Û·Î¹ú ÆÄÆ®³Ê ¸ÞÀϸµ ¼­ºñ½º ȸ»ç¼Ò°³È¸»ç¼Ò°³ Contact Us
English Japaness Chinese
Ä«Å×°í¸®
ÆÄ¸Ó½´Æ¼Äà (4512)
°¨¿°Áúȯ (322)
°ñÁúȯ Ä¡·á (48)
´ç´¢º´ (164)
¹é½Å (169)
ºñ¸¸Ä¡·á/´ÙÀÌ¾îÆ® (49)
ºñó¹æ ÀǾàǰ (149)
¼öÀÇÇÐ (17)
½Å°æÁúȯ (179)
½Å¾à°³¹ß (1306)
¾ÏÄ¡·á (856)
¾à¹°Àü´Þ (179)
ÀǾàǰ ±ÔÁ¦È¯°æ (105)
Á¤½ÅÁúȯ (88)
Á¦³×¸¯ ÀǾàǰ (116)
Á¦¾àȸ»çºÐ¼® (488)
󹿾à (128)
Áö¿ªº°°Ë»ö
ÃâÆÇ»ç¿¡¼­ ã±â

°ñÁúȯ Ä¡·á ½ÃÀåÁ¶»çº¸°í¼­

°ñÁúȯ Ä¡·á ½ÃÀåÀ» Á¶»ç ºÐ¼®ÇÑ ÀÚ·á·Î ½ÃÀå ±Ô¸ð, »ê¾÷ ºÐ¼®, ÇâÈÄ ½ÃÀå ¿¹Ãø µîÀÇ ³»¿ëÀ» ´Ù·ç°í ÀÖ½À´Ï´Ù.
º¸°í¼­¿¡ µû¶ó¼­ ÁÖ¿ä ±â¾÷ ºÐ¼®, °æÀïȯ°æ ºÐ¼®, ¿¬±¸°³¹ß ÇöȲ, ¿µ¾÷ Àü·«, ±â¾÷ Á¦ÈÞ ÇöȲÀ» Æ÷ÇÔÇÏ´Â °æ¿ìµµ ÀÖ½À´Ï´Ù.

»ó¼¼ºÐ·ù
Á¦¸ñ°Ë»ö
1 - 25 ¸®ºä (Àüü£º 41 °Ç) Á¤·Ä Ç¥½Ã °Ç¼ö
Musculoskeletal Disorders Therapeutics Market to 2017 - Osteoarthritis Market to Decline with Patent Expiry of Celebrex in 2014
»ùÇÃ
»óǰÄÚµå :227860
¼¼°èÀÇ ±Ù°ñ°Ý°èÁúȯ °ü·Ã ½ÃÀåÀ» ºÐ¼®ÇßÀ¸¸ç, ÃֽŠ¿¬±¸°³¹ß, Àü¼¼°è ¹× ÁÖ¿ä±¹ÀÇ ½ÃÀå µ¿Çâ, ÁÖ¿ä Áúȯ ´ÜÀ§º° »ó¼¼ÇÑ ½ÃÀå ±¸Á¶ ¹× µ¿Çâ, ÁÖ¿ä ±â¾÷ °³¿ä, ±â¾÷°£ Á¦ÈÞ µîÀÇ Á¤º¸¸¦ Á¤¸®ÇÏ¿© ÀüÇØµå¸³´Ï´Ù.
... ´õº¸±â
°¡°Ý US $ 3,500
¹ßÇàÀÏ 2012³â 01¿ù
¸®¼­Ä¡»ç GBI Research
ÆäÀÌÁö¼ö Pages: 159
Osteoarthritis (OA) Therapeutics - Pipeline Assessment and Market Forecasts to 2018
»ùÇÃ
»óǰÄÚµå :222446
º¯Çü¼º °üÀýÁõ(Osteoarthritis) Ä¡·á¹ý ¿¬±¸ °³¹ßÀÇ Ãֽе¿Çâ Á¶»ç¿Í °ü·Ã ½ÃÀåÀÇ ÇâÈÄ ¿¹Ãø, Áúȯ °³¿ä ¹× ´ëó¹ý, Àü¼¼°è ¹× ÁÖ¿ä 7°³±¹ÀÇ ½ÃÀå ±Ô¸ð ÃßÁ¤Ä¡ ¹× ¿¹Ãø(2005-2018³â), °æÀï ±¸µµ, ÀÓ»ó½ÃÇè ÁøÇà »óȲ¿¡ °üÇÑ ÆÄÀÌÇÁ¶óÀÎ Æò°¡, ÇâÈÄÀÇ ½ÃÀå µ¿Çâ ¹× ±â¾÷ Àü·«¿¡ °üÇÑ Àü·«Àû °íÂû µîÀÇ Á¤º¸¸¦ ÀüÇØµå¸³´Ï´Ù.
... ´õº¸±â
°¡°Ý US $ 3,500
¹ßÇàÀÏ 2011³â 11¿ù
¸®¼­Ä¡»ç GlobalData
ÆäÀÌÁö¼ö Pages: 80
»ùÇÃ
»óǰÄÚµå :217849
¼¼°è °¢±¹ÀÇ °ñ°¨¼ÒÁõ(Osteopenia) ÀÓ»ó½ÃÇèÀ» Á¶»çÇϰí, Áö¿ª, ÁøÃ´ »óȲ, ´Ü°è, ¸ðÁý »óȲº° ½Ç½Ã °Ç¼ö, ´ëÇ¥ÀûÀÎ ½ºÆù¼­, °³¹ßÁßÀÎ Ä¡·áÁ¦ Á¤º¸, °¢ ±â¾÷ ¹× ±â°ü¿¡¼­ÀÇ ÁøÇà »óȲ µîÀÇ Á¤º¸¸¦ ÀüÇØµå¸³´Ï´Ù.
... ´õº¸±â
°¡°Ý US $ 1,000
¹ßÇàÀÏ 2011³â 10¿ù
¸®¼­Ä¡»ç GlobalData
ÆäÀÌÁö¼ö Pages: 105
Multiple Myeloma Therapeutics - Pipeline Assessment and Market Forecasts to 2018
»ùÇÃ
»óǰÄÚµå :217226
´Ù¹ß¼º °ñ¼öÁ¾ÀÇ °³¿ä¿Í Áø´Ü, Ä¡·á¹ý, Ä¡·áÁ¦ ½ÃÀåÀÇ ±Ô¸ð¿Í 2018³â±îÁöÀÇ ¿¹Ãø, ÁÖ¿ä ½ÃÀ庰 µ¿Çâ, °³¹ß ÆÄÀÌÇÁ¶óÀÎ, Âü¿©±â¾÷ °³¿ä µîÀ» Á¤¸®ÇÏ¿© ÀüÇØµå¸³´Ï´Ù.
... ´õº¸±â
°¡°Ý US $ 3,500
¹ßÇàÀÏ 2011³â 10¿ù
¸®¼­Ä¡»ç GlobalData
ÆäÀÌÁö¼ö Pages: 111
»ùÇÃ
»óǰÄÚµå :225235
¼¼°èÀÇ ´Ù¹ß¼º °ñ¼öÁ¾(Multiple Myeloma) Ä¡·áÁ¦ ½ÃÀåÀ» ºÐ¼®Çϰí, ¹Ì±¹°ú À¯·´ÀÇ ºÎ¹®º° ½ÃÀå µ¿Çâ, 2009-2017³â ¿¹Ãø, ½ÃÀå ÁøÃâ ±â¾÷ °³¿ä µîÀ» ÀüÇØµå¸³´Ï´Ù.
... ´õº¸±â
°¡°Ý US $ 4,500
¹ßÇàÀÏ 2011³â 10¿ù
¸®¼­Ä¡»ç Global Industry Analysts, Inc.
ÆäÀÌÁö¼ö Pages: 595
Rheumatoid Arthritis: World Drug Market 2011-2021
»ùÇÃ
»óǰÄÚµå :220557
¼¼°èÀÇ ·ù¸¶Æ¼½º °üÀý¿° ½ÃÀå¿¡ ´ëÇØ Á¶»çºÐ¼®ÇßÀ¸¸ç, ÁÖ¿ä Á¦Ç°º° 2021³â±îÁöÀÇ ¸ÅÃâ ¿¹Ãø, Áö¿ªº° µ¿Çâ, ¿¬±¸°³¹ß, ½ÃÀå °æÀï°ú ±âȸ µîÀ» Á¤¸®ÇÏ¿© ÀüÇØµå¸³´Ï´Ù.
... ´õº¸±â
°¡°Ý US $ 2,642
¹ßÇàÀÏ 2011³â 09¿ù
¸®¼­Ä¡»ç Visiongain
ÆäÀÌÁö¼ö 138 Pages
Global Osteoporosis Market & Drugs Analysis 2010 - 2015
»ùÇÃ
»óǰÄÚµå :210160
¼¼°èÀÇ °ñ´Ù°øÁõ(Osteoporosis) ½ÃÀå¿¡ ´ëÇØ Á¶»ç ºÐ¼®Çϰí, 4°³ ¾àÁ¦ Ŭ·¡½º¿¡ °üÇÑ ½ÃÀå Á¡À¯À² µ¥ÀÌÅÍ(2006-2014³â), 9°³ ¾àÁ¦ ºê·£µåÀÇ 2007-2015³â ¸ÅÃâ ¹× ½ÃÀå Á¡À¯À², Áö¿ªº° µ¿Çâ, ÆÄÀÌÇÁ¶óÀÎ °³¹ß°ú ÇâÈÄ Àü¸Á¿¡ ´ëÇØ Á¤¸®ÇÏ¿© ÀüÇØµå¸³´Ï´Ù.
... ´õº¸±â
°¡°Ý US $ 950
¹ßÇàÀÏ 2011³â 09¿ù
¸®¼­Ä¡»ç Renub Research
ÆäÀÌÁö¼ö 72 Pages
Worldwide Spine Surgery 2011: Products, Technologies, Markets & Opportunities, 2010-2020
»ùÇÃ
»óǰÄÚµå :201350
¼¼°èÀÇ Ã´Ãß ¼ö¼ú(Spine Surgery) ½ÃÀåÀ» »ó¼¼ÇÏ°Ô ºÐ¼®Çϰí, ôÃß Áúȯ °³¿ä ¹× ȯÀÚ µ¿Çâ, ÇöÀçÀÇ Ä¡·á °ü¸®, ±â¼ú µ¿Çâ, Á¦Ç° ¿¹Ãø, ÇâÈÄ 10³â°£ÀÇ Áö¿ª ¹× ±¹°¡º° ½Ã¼ú °Ç¼ö ¿¹Ãø, Æò±Õ ÆÇ¸Å °¡°Ý, Á¦Á¶¾÷ÀÚÀÇ ¸ÅÃâ µîÀ» Á¤¸®ÇÏ¿© ÀüÇØµå¸³´Ï´Ù.
... ´õº¸±â
°¡°Ý US $ 3,750
¹ßÇàÀÏ 2011³â 07¿ù
¸®¼­Ä¡»ç MedMarket Diligence
ÆäÀÌÁö¼ö 635 Pages
Key Companies: Osteoporosis - Growing competition threatens leading franchises and drives innovation
»ùÇÃ
»óǰÄÚµå :207802
°ñ´Ù°øÁõ Ä¡·á ½ÃÀå¿¡ °ü¿©ÇÏ´Â ÁÖ¿ä ±â¾÷ÀÇ ºê·£µå ¼ö¸íÁÖ±â ¹× Æ÷Æ®Æú¸®¿À °ü¸® Àü·«¿¡ ´ëÇÑ °íÂû°ú Merck & Co.¹× ServierÀÇ °ñ´Ù°øÁõ Æ÷Æ®Æú¸®¿À °ü¸® Àü·«°ú °úÁ¦¿¡ ´ëÇÑ »ç·Ê¿¬±¸, º» ºÐ¾ß¿¡¼­ Ȱ¾àÇÏ´Â ±â¾÷ÀÇ Àü·« µ¿Çâ, ÃÖ±ÙÀÇ Áß¿ä ¶óÀ̼¾½º °è¾à¿¡ ÀÇÇÑ ¿µÇâ µî ÃֽŠÁ¶»ç Á¤º¸¸¦ Á¤¸®ÇÏ¿© ÀüÇØµå¸³´Ï´Ù.
... ´õº¸±â
°¡°Ý US $ 3,800
¹ßÇàÀÏ 2011³â 07¿ù
¸®¼­Ä¡»ç Datamonitor
ÆäÀÌÁö¼ö Pages: 34
Epidemiology: Osteopenia and Osteoporosis - On the rise as the aging population grows
»ùÇÃ
»óǰÄÚµå :206499
ÇâÈÄ 10³â°£ÀÇ ¹Ì±¹, ÀϺ», À¯·´ 5°³±¹¿¡¼­ÀÇ °ñ°¨¼ÒÁõ(Osteopenia), °ñ´Ù°øÁõ(Osteoporosis) À¯º´ °Ç¼ö ¿¹Ãø, ¿ªÇÐÀû À§ÇèÀÎÀÚ µî¿¡ ´ëÇØ Á¤¸®ÇÏ¿© ÀüÇØµå¸³´Ï´Ù.
... ´õº¸±â
°¡°Ý US $ 5,700
¹ßÇàÀÏ 2011³â 07¿ù
¸®¼­Ä¡»ç Datamonitor
ÆäÀÌÁö¼ö Pages: 55
Osteopenia Global Clinical Trials Review, Q2, 2011
»ùÇÃ
»óǰÄÚµå :204625
°ñ°¨¼ÒÁõ(Osteopenia)¿¡ ´ëÇÑ Áö¿ªº°, ±¹°¡º°, »ó(ßÓ)º° ÀÓ»ó½ÃÇè µ¿ÇâÀ» Æ÷°ýÀûÀÎ µ¥ÀÌÅÍ·Î Á¤¸®Çϰí, ÁÖ¿ä ±â¾÷, ÀÇ·á±â°ü, ´ëÇÐ, º´¿ø µî¿¡¼­ ½Ç½ÃÇϰí ÀÖ´Â ÀÓ»ó½ÃÇè ³»¿ë, °³¹ßÁßÀÎ ¾àÁ¦ µ¿Çâ µîÀ» Á¤¸®ÇÏ¿© ÀüÇØµå¸³´Ï´Ù.
... ´õº¸±â
°¡°Ý US $ 1,000
¹ßÇàÀÏ 2011³â 06¿ù
¸®¼­Ä¡»ç GlobalData
ÆäÀÌÁö¼ö Pages: 68
Post Menopausal Osteoporosis Global Clinical Trials Review, Q2, 2011
»ùÇÃ
»óǰÄÚµå :204346
Æó°æÈÄ °ñ´Ù°øÁõ(Post Menopausal Osteoporosis)¿¡ ´ëÇÑ Áö¿ªº°, ±¹°¡º°, »ó(ßÓ)º° ÀÓ»ó½ÃÇè µ¿ÇâÀ» Æ÷°ýÀû µ¥ÀÌÅÍ·Î Á¤¸®Çϰí, ÁÖ¿ä ±â¾÷, ÀÇ·á±â°ü, ´ëÇÐ, º´¿ø µî¿¡¼­ ½Ç½ÃµÇ°í ÀÖ´Â ÀÓ»ó½ÃÇèÀÇ ³»¿ë, °³¹ßÁßÀÎ ¾àÁ¦ µ¿Çâ µîÀ» Á¤¸®ÇÏ¿© ÀüÇØµå¸³´Ï´Ù.
... ´õº¸±â
°¡°Ý US $ 1,000
¹ßÇàÀÏ 2011³â 06¿ù
¸®¼­Ä¡»ç GlobalData
ÆäÀÌÁö¼ö Pages: 76
Product Profiles: Osteoporosis - Novel candidates offer the greatest potential
»ùÇÃ
»óǰÄÚµå :203575
ȯÀÚ¼ö Áõ°¡¿Í ÇÔ²² ÀáÀçÀûÀ¸·Î ³ôÀº ¼öÀͼºÀÌ ±â´ëµÇ´Â °ñ´Ù°øÁõ Ä¡·áÁ¦ ½ÃÀå¿¡ ´ëÇØ ¸ðµç Ãâ½ÃµÇ°í ÀÖ´Â Ä¡·á¾à°ú ÆÄÀÌÇÁ¶óÀÎÀ» Á¶»çºÐ¼®Çϰí, °á°ú¸¦ ÇÔ²² ÀüÇØµå¸³´Ï´Ù.
... ´õº¸±â
°¡°Ý US $ 11,400
¹ßÇàÀÏ 2011³â 06¿ù
¸®¼­Ä¡»ç Datamonitor
ÆäÀÌÁö¼ö Pages: 208
Myelodysplastic Syndrome Therapeutics - Pipeline Assessment and Market Forecasts to 2017
»ùÇÃ
»óǰÄÚµå :200530
°ñ¼öÀÌÇü¼ºÁõÈıº(Myelodysplastic Syndromen) Ä¡·áÁ¦ ½ÃÀå¿¡ ´ëÇØ °£·«ÇÏ°Ô ¼³¸íÇϰí, ÁÖ¿ä ±¹°¡ ½ÃÀåÀÇ ±Ô¸ð ¹× 2017³â±îÁöÀÇ ¿¹Ãø, °æÀï µ¿Çâ, ÆÄÀÌÇÁ¶óÀÎ ¾àÁ¦ °³¿ä, °¢»çÀÇ Àü·« µîÀ» Á¤¸®ÇÏ¿© ÀüÇØµå¸³´Ï´Ù.
... ´õº¸±â
°¡°Ý US $ 2,000
¹ßÇàÀÏ 2011³â 06¿ù
¸®¼­Ä¡»ç GlobalData
ÆäÀÌÁö¼ö Pages: 89
Osteoporosis Global Clinical Trials Review, Q1, 2011
»ùÇÃ
»óǰÄÚµå :196167
°ñ´Ù°øÁõ Ä¡·áÁ¦¿¡ °üÇÑ ÀÓ»ó½ÃÇè µ¿Çâ¿¡ ´ëÇØ ÀÓ»ó½ÃÇè¼ö ¹× ÇÇÇèÀÚ¼ö, ´Ü°èº° ¹× »ó(Phase)º° »óȲ, À¯¸Á ±â¾÷, °³¹ßÁßÀÎ ÀÓ»ó½ÃÇè ¼ö ¹× Á¤º¸ µîÀ» ÀüÇØµå¸³´Ï´Ù.
... ´õº¸±â
°¡°Ý US $ 1,000
¹ßÇàÀÏ 2011³â 04¿ù
¸®¼­Ä¡»ç GlobalData
ÆäÀÌÁö¼ö Pages: 77
R&D Trends: Osteoporosis - Strong pipeline bodes well for future treatment
»ùÇÃ
»óǰÄÚµå :180915
°ñ´Ù°øÁõ(Osteoporosis) Ä¡·á ¿¬±¸°³¹ß ÆÄÀÌÇÁ¶óÀÎÀÇ ÁÖ¿ä µ¿Çâ¿¡ ´ëÇØ ºÐ¼®Çϰí, ½Å¿ä¹ý, ±âÁ¸¿ä¹ý¿¡ ´ëÇÑ Æò°¡, ÇöÀç±îÁö ½Ç½ÃµÈ ÀÓ»ó½ÃÇè, ÁßÁöµÈ ÀÓ»ó½ÃÇè µîÀ» Æò°¡ÇÔÀ¸·Î½á R&D ÀÇ»ç°áÁ¤À» Áö¿øÇϰí, ÇâÈÄ 20³â°£ÀÇ ¿¹Ãø µîÀ» Á¤¸®ÇÏ¿© ÀüÇØµå¸³´Ï´Ù.
... ´õº¸±â
°¡°Ý US $ 3,800
¹ßÇàÀÏ 2011³â 04¿ù
¸®¼­Ä¡»ç Datamonitor
ÆäÀÌÁö¼ö Pages: 49
Bone Metastases Therapeutics - Pipeline Assessment and Market Forecasts to 2017
»ùÇÃ
»óǰÄÚµå :180368
¼¼°èÀÇ °ñÀüÀÌ(Bone Metastases) Ä¡·áÁ¦ ½ÃÀå¿¡ ´ëÇÑ ÆÄÀÌÇÁ¶óÀÎ ºÐ¼® ¹× 2017³â±îÁöÀÇ ½ÃÀå ¿¹Ãø, ½ÃÀå Æ¯Â¡, °æÀï, ±â¾÷ °³¿ä µîÀ» ÀüÇØµå¸³´Ï´Ù.
... ´õº¸±â
°¡°Ý US $ 2,000
¹ßÇàÀÏ 2011³â 04¿ù
¸®¼­Ä¡»ç GlobalData
ÆäÀÌÁö¼ö Pages: 84
Bone and Joint Infection Market to 2016 - Medical Imaging and PCR Methods to Facilitate Early Diagnosis and Treatment
»ùÇÃ
»óǰÄÚµå :170800
¼¼°èÀÇ °ñ ¹× °üÀý °¨¿° Ä¡·áÁ¦ ½ÃÀåÀ» ºÐ¼®ÇßÀ¸¸ç, ½ÃÀåÀÇ ¸ÅÃâ±Ô¸ð µ¿Çâ, Áö¿ªº°, Ä¡·á ºÐ¾ßº° µ¿Çâ, Èıⰳ¹ß ´Ü°è¿¡ ÀÖ´Â ¾àÁ¦ÀÇ °³¿ä ¹× Âü¿© ±â¾÷ÀÇ °æÀï °³¿ä µîÀ» Á¤¸®ÇÏ¿© ÀüÇØµå¸³´Ï´Ù.
... ´õº¸±â
°¡°Ý US $ 3,500
¹ßÇàÀÏ 2011³â 02¿ù
¸®¼­Ä¡»ç GBI Research
ÆäÀÌÁö¼ö Pages: 121
»ùÇÃ
»óǰÄÚµå :169870
¼¼°èÀÇ °ñ´Ù°øÁõ Ä¡·á(Osteoporosis Therapeutics) ½ÃÀåÀ» Á¶»ç ºÐ¼®Çϰí, »ê¾÷ÀÇ °³¿ä, ½ÃÀåÀÇ Àü¸Á, ÁÖ¿ä Ä¡·áÀÇ ºÐ·ù, ½ÃÀå ¿ªÇÐ, Á¦Ç°ÀÇ °³¿ä, Á¦Ç°ÀÇ µµÀÔ°ú Àΰ¡, ÃÖ±ÙÀÇ »ê¾÷ Ȱµ¿, ÁÖ¿ä ±â¾÷ÀÇ °³¿ä, ¼¼°è ½ÃÀåÀÇ Àü¸Á, °¢±¹ ½ÃÀåÀÇ °³¿ä µîÀ» ÀüÇØµå¸³´Ï´Ù.
... ´õº¸±â
°¡°Ý US $ 4,500
¹ßÇàÀÏ 2011³â 01¿ù
¸®¼­Ä¡»ç Global Industry Analysts, Inc.
ÆäÀÌÁö¼ö Pages: 434
Paget's disease of Bone - Pipeline Assessment and Market Forecasts to 2017
»ùÇÃ
»óǰÄÚµå :138955
¼¼°è »ÀÀÇ ÆÄÁ¬º´(Paget''s disease of bone) Ä¡·áÁ¦ ½ÃÀå¿¡ ´ëÇÑ ÆÄÀÌÇÁ¶óÀÎ(Pipeline) ºÐ¼®°ú 2017³â±îÁöÀÇ ½ÃÀåÀ» ¿¹ÃøÇϰí, ½ÃÀåÀÇ Æ¯Â¡, °æÀï, ÆÄÀÌÇÁ¶óÀÎ µîÀ» Æò°¡ºÐ¼®ÇÏ¿© ÇâÈÄ ½ÃÀå °æÀï ¹× ±â¾÷ °³¿ä¿Í ÇÔ²² ÀüÇØµå¸³´Ï´Ù.
... ´õº¸±â
°¡°Ý US $ 2,000
¹ßÇàÀÏ 2010³â 12¿ù
¸®¼­Ä¡»ç GlobalData
ÆäÀÌÁö¼ö Pages: 31
»ùÇÃ
»óǰÄÚµå :138953
¼¼°èÀÇ ÅðÇ༺ °üÀý¿°(Osteoarthritis) Ä¡·áÁ¦ ½ÃÀå¿¡ ´ëÇÑ ÆÄÀÌÇÁ¶óÀÎ(Pipeline) ºÐ¼®°ú 2017³â±îÁöÀÇ ½ÃÀåÀ» ¿¹ÃøÇϰí, ½ÃÀåÀÇ Æ¯Â¡, °æÀï, ÆÄÀÌÇÁ¶óÀÎ µîÀ» Æò°¡ºÐ¼®ÇÏ¿© ÇâÈÄ ½ÃÀå °æÀï ¹× ±â¾÷ °³¿ä¿Í ÇÔ²² ÀüÇØµå¸³´Ï´Ù.
... ´õº¸±â
°¡°Ý US $ 2,000
¹ßÇàÀÏ 2010³â 12¿ù
¸®¼­Ä¡»ç GlobalData
ÆäÀÌÁö¼ö Pages: 42
Osteoporosis - Pipeline Assessment and Market Forecasts to 2017
»ùÇÃ
»óǰÄÚµå :134732
¼¼°è °ñ´Ù°øÁõ ½ÃÀå¿¡ ´ëÇØ ÁÖ¿ä µ¿Çâ, ½ÃÀåÀÇ ÃËÁø¿äÀÎ ¹× °æÀï Àü¸Á, ÆÄÀÌÇÁ¶óÀÎ Á¦Ç° Á¶»ç, ÁÖ¿ä ±â¾÷ÀÇ °³¿ä µîÀ» ÀüÇØµå¸³´Ï´Ù.
... ´õº¸±â
°¡°Ý US $ 2,000
¹ßÇàÀÏ 2010³â 09¿ù
¸®¼­Ä¡»ç GlobalData
ÆäÀÌÁö¼ö Pages: 50
U.S. Markets for Musculoskeletal Tissue Engineering Products
»ùÇÃ
»óǰÄÚµå :129389
±Ù°ñ°Ý Á¶Á÷ ¿£Áö´Ï¾î¸µÀÇ °³¿ä¿Í ÇöÀçÀÇ »ýüÀç·á(Biomaterials, ¹ÙÀÌ¿À¸ÅÆ®¸®¾ó), ¼¼Æ÷À̽Ä, À¯ÀüÀÚÄ¡·á, Áٱ⼼Æ÷, Á¶Á÷ Àç»ý ±â¼úÀÇ °³¿ä, Âü¿©±â¾÷ °³¿ä µîÀ» Á¤¸®ÇÏ¿© ÀüÇØµå¸³´Ï´Ù.
... ´õº¸±â
°¡°Ý US $ 4,750
¹ßÇàÀÏ 2010³â 07¿ù
¸®¼­Ä¡»ç Medtech Insight
ÆäÀÌÁö¼ö 156 Pages
Therapeutics and Biomaterials for Musculoskeletal Disease: Global Markets
»ùÇÃ
¿­¶÷ ¼­ºñ½º Á¦°ø
»óǰÄÚµå :125940
±Ù°ñ°Ý ÁúȯÀÇ °³¿ä¿Í ´Ù¾çÇÑ Ä¡·á¹ý °³¿ä, ±Ù°ñ°Ý Áúȯ ½ÃÀåÀÇ ¹ýÀû ȯ°æ, ÆÄÀÌÇÁ¶óÀÎ(Pipeline), ½ÃÀå ÁøÃâ ±â¾÷ÀÇ °³¿ä µîÀ» Á¤¸®ÇÏ¿© ÀüÇØµå¸³´Ï´Ù.
... ´õº¸±â
°¡°Ý US $ 4,850
¹ßÇàÀÏ 2010³â 07¿ù
¸®¼­Ä¡»ç BCC Research
ÆäÀÌÁö¼ö 215 Pages
Pipeline Insight: Osteoporosis - Bone building drugs become the heart of the pipeline
»ùÇÃ
»óǰÄÚµå :134493
¼¼°è 7´ë ½ÃÀå ¹× BRIC ±¹°¡ÀÇ °ñ´Ù°øÁõ(Osteoporosis) ȯÀÚ µ¿Çâ, À¯·´ ¹× ÀϺ» ¿ÀÇǴϾ𠸮´õ(Opinion Leader)ÀÇ ÀÓ»óÀû, ȯ°æ»ó ¹ÌÃæÁ· ¿å±¸(Unmet Needs)¿¡ ´ëÇÑ °ßÇØ, Ç¥Àû Á¦Ç° ÇÁ·ÎÆÄÀÏ µîÀ» ÀüÇØµå¸³´Ï´Ù.
... ´õº¸±â
°¡°Ý US $ 11,400
¹ßÇàÀÏ 2010³â 07¿ù
¸®¼­Ä¡»ç Datamonitor
ÆäÀÌÁö¼ö Pages: 284